Works by Huang, Yi-Hsiang


Results: 177
    1
    2

    ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.

    Published in:
    Journal of Hepatocellular Carcinoma, 2025, v. 12, p. 671, doi. 10.2147/JHC.S462701
    By:
    • Stefanini, Bernardo;
    • Fulgenzi, Claudia Angela Maria;
    • Scheiner, Bernhard;
    • Korolewicz, James;
    • Cheon, Jaekyung;
    • Nishida, Naoshi;
    • Ang, Celina;
    • Marron, Thomas U;
    • Wu, Y Linda;
    • Saeed, Anwaar;
    • Wietharn, Brooke;
    • Rimassa, Lorenza;
    • Pirozzi, Angelo;
    • Cammarota, Antonella;
    • Pressiani, Tiziana;
    • Pinter, Matthias;
    • Balcar, Lorenz;
    • Huang, Yi-Hsiang;
    • Mehan, Aman;
    • Phen, Samuel
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    24
    25
    26
    27

    Large‐scale genome‐wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 682, doi. 10.1111/apt.15887
    By:
    • Huang, Yu‐Han;
    • Liao, Shu‐Fen;
    • Khor, Seik‐Soon;
    • Lin, Yu‐Ju;
    • Chen, Hsuan‐Yu;
    • Chang, Ya‐Hsuan;
    • Huang, Yi‐Hsiang;
    • Lu, Sheng‐Nan;
    • Lee, Hye‐Won;
    • Ko, Wen‐Ya;
    • Huang, Claire;
    • Liu, Po‐Chun;
    • Chen, Yen‐Ju;
    • Wu, Ping‐Feng;
    • Chu, Hou‐Wei;
    • Wu, Pei‐Ei;
    • Tokunaga, Katsushi;
    • Shen, Chen‐Yang;
    • Lee, Mei‐Hsuan
    Publication type:
    Article
    28

    Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1290, doi. 10.1111/apt.15011
    By:
    • Liu, Chen‐Hua;
    • Yu, Ming‐Lung;
    • Peng, Cheng‐Yuan;
    • Hsieh, Tsai‐Yuan;
    • Huang, Yi‐Hsiang;
    • Su, Wei‐Wen;
    • Cheng, Pin‐Nan;
    • Lin, Chih‐Lin;
    • Lo, Ching‐Chu;
    • Chen, Chi‐Yi;
    • Chen, Jyh‐Jou;
    • Ma, Qian;
    • Brooks‐Rooney, Craig;
    • Kao, Jia‐Horng
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.

    Published in:
    BioMed Research International, 2019, p. 1, doi. 10.1155/2019/6740616
    By:
    • Tsai, Hung-Cheng;
    • Chang, Fu-Pang;
    • Li, Tzu-Hao;
    • Liu, Chih-Wei;
    • Huang, Chia-Chang;
    • Huang, Shiang-Fen;
    • Yang, Ying-Ying;
    • Lee, Kuei-Chuan;
    • Hsieh, Yun-Cheng;
    • Wang, Ying-Wen;
    • Lee, Tzung-Yan;
    • Huang, Yi-Hsiang;
    • Hou, Ming-Chih;
    • Lin, Han-Chieh
    Publication type:
    Article
    45
    46
    47
    48
    49
    50